Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kumar, R.
Right arrow Articles by Hansen, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, R.
Right arrow Articles by Hansen, N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Patent Prosecution Strategies for Stem Cell–Related Applications

Rajeev Kumar

Fernandez & Associates LLP, Menlo Park, California, Kumarrajv{at}gmail.com

Jenny J. Yeh

Fernandez & Associates LLP, Menlo Park, California

Dennis Fernandez

Fernandez & Associates LLP, Menlo Park, California

Nels Hansen

Fernandez & Associates LLP, Menlo Park, California

Stem cell research and the intellectual property derived from it, because of its potential to completely transform health care, demand an especially high level of consideration from business and patent prosecution perspectives. As with other revolutionary technologies, ordinary risks are amplified (e.g., litigation), and ordinarily irrelevant considerations may become important (e.g., heightened level of both domestic and foreign legislative risk). In the first part of this article, general strategies for patent prosecutors such as several prosecution considerations and methods for accelerating patent prosecution process are presented. In the second part, patent prosecution challenges of stem cell—related patents and possible solutions are discussed. In the final part, ethical and public policy issues particular to stem cell—related and other biotechnological inventions are summarized. (Journal of Biomolecular Screening 2007:769-774)

Key Words: stem cell • patent • prosecution

Journal of Biomolecular Screening, Vol. 12, No. 6, 769-774 (2007)
DOI: 10.1177/1087057107305828
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
V. S. Nirmalanandhan and G. S. Sittampalam
Stem Cells in Drug Discovery, Tissue Engineering, and Regenerative Medicine: Emerging Opportunities and Challenges
J Biomol Screen, August 1, 2009; 14(7): 755 - 768.
[Abstract] [PDF]